The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II

The U.S. Preventive Services Task Force (USPSTF) has recommended against PSA-based screening for prostate cancer due to potential possibilities of false-results. Since no alternative test is available to replace it, we have initiated a trial with the purpose of establishing whether Galectin-3 (Gal-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Kosei, Heilbrun, Lance K, Smith, Daryn, Hogan, Victor, Raz, Avraham, Heath, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392275/
https://www.ncbi.nlm.nih.gov/pubmed/27741522
http://dx.doi.org/10.18632/oncotarget.12620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392275/
https://www.ncbi.nlm.nih.gov/pubmed/27741522
http://dx.doi.org/10.18632/oncotarget.12620

Ejemplares similares